UNII FZ989GH94E

POVIDONE, UNSPECIFIED

Unique Ingredient Identifier FZ989GH94E is listed as a unspecified ingredient
UniiFZ989GH94E
Preferred Substance NamePOVIDONE, UNSPECIFIED
Rn9003-39-8
NcitC77491
Rxcui8610
Inn Id2549
Unii TypeUNSPECIFIED INGREDIENT
RN9003-39-8
NCITC77491
RXCUI8610
INN ID2549

Alternate Names

Dosage Forms

UNII FZ989GH94E POVIDONE, UNSPECIFIED is commonly included in medications in the following forms.

RouteDosage FormPotency
ORALTABLET0.97 mg
AURICULAR (OTIC)SUSPENSION NA
INTRAMUSCULARINJECTION0.9 %
INTRAVENOUSINJECTABLE2 %
INTRAVENOUSINJECTION1 %
IV(INFUSION)INJECTION NA
OPHTHALMICSOLUTION2 %
OPHTHALMICSOLUTION, DROPS1.8 %
OPHTHALMICSUSPENSION1.8 %
OPHTHALMICSUSPENSION, DROPS1.5 %
ORALCAPSULE130 MG
ORALCAPSULE, COATED PELLETS10.03 MG
ORALCAPSULE, COATED, SOFT GELATIN6.9 MG
ORALCAPSULE, DELAYED ACTION, ENTERIC COATED NA
ORALCAPSULE, DELAYED RELEASE8.7 MG
ORALCAPSULE, ENTERIC COATED PELLETS9.2 MG
ORALCAPSULE, EXTENDED RELEASE102.73 MG
ORALCAPSULE, HARD GELATIN50 MG
ORALCAPSULE, SOFT GELATIN NA
ORALCAPSULE, SUSTAINED ACTION72 MG
ORALCAPSULE, SUSTAINED ACTION, HARD GELATIN10.43 MG
ORALDISPERSIBLE TABLET2 MG
ORALDROPS NA
ORALGRANULE100 MG
ORALGRANULE, EFFERVESCENT NA
ORALGRANULE, FOR ORAL SUSPENSION75 MG
ORALGRANULE, FOR SUSPENSION NA
ORALGRANULE, FOR SUSPENSION, EXTENDED RELEASE NA
ORALPOWDER, FOR ORAL SOLUTION4.5 MG
ORALPOWDER, FOR ORAL SUSPENSION5.85 MG/5ML
ORALPOWDER, FOR RECONSTITUTION NA
ORALPOWDER, FOR SUSPENSION35 MG/5ML
ORALSOLUTION250 MG/5ML
ORALSUSPENSION1.57 MG/1ML
ORALSUSPENSION, EXTENDED RELEASE5.21 MG/5ML
ORALTABLET (IMMED./COMP. RELEASE), COATED3 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED240 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL4 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE18 MG
ORALTABLET, CHEWABLE21 MG
ORALTABLET, COATED49.2 MG
ORALTABLET, CONTROLLED RELEASE219.03 MG
ORALTABLET, DELAYED ACTION73.7 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED35 MG
ORALTABLET, DISPERSIBLE2 MG
ORALTABLET, EXTENDED RELEASE371.25 MG
ORALTABLET, FILM COATED116 MG
ORALTABLET, ORALLY DISINTEGRATING15.03 MG
ORALTABLET, REPEAT ACTION10 MG
ORALTABLET, SUSTAINED ACTION300 MG
ORALTABLET, SUSTAINED ACTION, COATED17 MG
ORALTABLET, SUSTAINED ACTION, FILM COATED53.33 MG
ORALTABLET, UNCOATED, TROCHE35 MG
SUBCUTANEOUSIMPLANT6 MG
SUBLINGUALTABLET12 MG
TOPICALEMULSION, CREAM NA
TOPICALLOTION NA
TOPICALPATCH NA
TOPICALSOLUTION4 %W/W
TRANSDERMALFILM, CONTROLLED RELEASE9.69 MG
TRANSDERMALPATCH, CONTROLLED RELEASE20 MG
TRANSDERMALSOLUTION2.44 %
VAGINALINSERT49 MG
VAGINALTABLET50 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.